PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
HMCA.L vs. NUCG.L
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


HMCA.LNUCG.L
YTD Return22.53%40.41%
1Y Return17.16%48.81%
Sharpe Ratio0.561.21
Sortino Ratio1.121.92
Omega Ratio1.151.30
Calmar Ratio0.462.28
Martin Ratio1.924.70
Ulcer Index8.22%10.65%
Daily Std Dev28.35%41.41%
Max Drawdown-34.60%-21.97%
Current Drawdown-16.13%-2.78%

Correlation

-0.50.00.51.00.2

The correlation between HMCA.L and NUCG.L is 0.15, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

HMCA.L vs. NUCG.L - Performance Comparison

In the year-to-date period, HMCA.L achieves a 22.53% return, which is significantly lower than NUCG.L's 40.41% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-20.00%-10.00%0.00%10.00%20.00%30.00%MayJuneJulyAugustSeptemberOctober
10.69%
20.24%
HMCA.L
NUCG.L

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


HMCA.L vs. NUCG.L - Expense Ratio Comparison

HMCA.L has a 0.30% expense ratio, which is lower than NUCG.L's 0.55% expense ratio.


NUCG.L
VanEck Uranium and Nuclear Technologies UCITS ETF
Expense ratio chart for NUCG.L: current value at 0.55% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.55%
Expense ratio chart for HMCA.L: current value at 0.30% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.30%

Risk-Adjusted Performance

HMCA.L vs. NUCG.L - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for HSBC MSCI CHINA A UCITS ETF (HMCA.L) and VanEck Uranium and Nuclear Technologies UCITS ETF (NUCG.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


HMCA.L
Sharpe ratio
The chart of Sharpe ratio for HMCA.L, currently valued at 0.80, compared to the broader market-2.000.002.004.006.000.80
Sortino ratio
The chart of Sortino ratio for HMCA.L, currently valued at 1.49, compared to the broader market0.005.0010.001.49
Omega ratio
The chart of Omega ratio for HMCA.L, currently valued at 1.20, compared to the broader market1.001.502.002.503.003.501.20
Calmar ratio
The chart of Calmar ratio for HMCA.L, currently valued at 0.83, compared to the broader market0.005.0010.0015.000.83
Martin ratio
The chart of Martin ratio for HMCA.L, currently valued at 3.30, compared to the broader market0.0020.0040.0060.0080.00100.00120.003.30
NUCG.L
Sharpe ratio
The chart of Sharpe ratio for NUCG.L, currently valued at 1.21, compared to the broader market-2.000.002.004.006.001.21
Sortino ratio
The chart of Sortino ratio for NUCG.L, currently valued at 1.92, compared to the broader market0.005.0010.001.92
Omega ratio
The chart of Omega ratio for NUCG.L, currently valued at 1.30, compared to the broader market1.001.502.002.503.003.501.30
Calmar ratio
The chart of Calmar ratio for NUCG.L, currently valued at 2.28, compared to the broader market0.005.0010.0015.002.28
Martin ratio
The chart of Martin ratio for NUCG.L, currently valued at 4.70, compared to the broader market0.0020.0040.0060.0080.00100.00120.004.70

HMCA.L vs. NUCG.L - Sharpe Ratio Comparison

The current HMCA.L Sharpe Ratio is 0.56, which is lower than the NUCG.L Sharpe Ratio of 1.21. The chart below compares the historical Sharpe Ratios of HMCA.L and NUCG.L, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.50MayJuneJulyAugustSeptemberOctober
0.80
1.21
HMCA.L
NUCG.L

Dividends

HMCA.L vs. NUCG.L - Dividend Comparison

HMCA.L's dividend yield for the trailing twelve months is around 196.05%, while NUCG.L has not paid dividends to shareholders.


TTM20232022202120202019
HMCA.L
HSBC MSCI CHINA A UCITS ETF
196.05%220.18%175.95%109.02%88.31%177.84%
NUCG.L
VanEck Uranium and Nuclear Technologies UCITS ETF
0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

HMCA.L vs. NUCG.L - Drawdown Comparison

The maximum HMCA.L drawdown since its inception was -34.60%, which is greater than NUCG.L's maximum drawdown of -21.97%. Use the drawdown chart below to compare losses from any high point for HMCA.L and NUCG.L. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%MayJuneJulyAugustSeptemberOctober
-16.84%
-2.78%
HMCA.L
NUCG.L

Volatility

HMCA.L vs. NUCG.L - Volatility Comparison

HSBC MSCI CHINA A UCITS ETF (HMCA.L) has a higher volatility of 18.76% compared to VanEck Uranium and Nuclear Technologies UCITS ETF (NUCG.L) at 10.25%. This indicates that HMCA.L's price experiences larger fluctuations and is considered to be riskier than NUCG.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%MayJuneJulyAugustSeptemberOctober
18.76%
10.25%
HMCA.L
NUCG.L